phase readout
saveNCT07459647: A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: MapLight Therapeutics. Phase: PHASE2. Conditions: Schizophrenia
view source ↗Sponsor: MapLight Therapeutics. Phase: PHASE2. Conditions: Schizophrenia
view source ↗
comments(0)
5-min edit window · permanent after that